亚太地区医疗技术行业市场前景及投资研究报告-培训课件外文版2024.6

INDUSTRIES

&

MARKETSMedicaltechnologyintheAsia-PacificregionCHAPTER

01GlobaloverviewRevenueinthemedicaltechnologymarketWorldwidefrom2016to2028(inbillionU.S.dollars)RevenueinthemedicaltechnologymarketWorldwide2016-2028800700600500400300200100020162017201820192020202120222023202420252026202720283Description:Theglobalrevenueinthemedicaltechnologymarketwasforecasttocontinuouslyincreasebetween2024and2028byintotal138billionU.S.dollars(+22.62percent).Aftertheeighthconsecutiveincreasingyear,theindicatorisestimatedtoreach748.17billionU.S.dollarsandthereforeanewpeakin2028.ReadmoreNote(s):Worldwide;2016to2028Source(s):MarketInsightsAnnualsizeoftheinvitrodiagnostics(IVD)marketworldwidebetween2020and2030(inbillionU.S.dollars)Invitrodiagnostics(IVD)marketsizeworldwide2020-2030140118.6115.4120112.1108.8105.4101.998.51008060402009591.286.579.72020202120222023*2024*2025*2026*2027*2028*2029*2030*4Description:In2022,accordingtodatafromNextMoveStrategyConsulting,theglobalinvitrodiagnostics(IVD)marketwasworthapproximately91.2billionU.S.dollars.By2030,theIVDmarketwasforecasttobeworthover118billionU.S.dollarswithaCAGR(between2023and2030)of3.2percent.ReadmoreNote(s):Worldwide;2023;*Forecast.ReadmoreSource(s):NextMoveStrategyConsultingLeadingmedicaltechnologycompaniesworldwidebasedonrevenuein2022(inbillionU.S.dollars)Medicaltechnology-topcompaniesbasedonrevenue2022RevenueinbillionU.S.dollars15051020253035AbbottMedtronicInc.Johnson&JohnsonSiemensHealthineersBectonDickinsonGEHealthcareStryker31.2731.2327.4321.1318.8718.4618.45Philips16.515.89CardinalHealthBaxter15.115Description:In2022,witharevenueofapproximately31.3billionU.S.dollars,AbbottLaboratories.wastheleadingmedicaltechnologycompanyintheworld.Thelargestmedicaldevicessegmentwithinthecompanywasfordiabetescare,followedbyvascularapplicationsandrhythmmanagementdevices.TheUnitedStateswasbyfarthemostimportantgeographicalregionforAbbottwhichisbasedinChicago,Illinois.ReadmoreNote(s):WorldwideSource(s):MedicalProductOutsourcingRankingofthegloballeading10healthcareequipmentandservicescompaniesbasedonrevenuein2023(inbillionU.S.dollars)Globallistoftophealthcareequipmentandservicecompaniesbasedonrevenue2023RevenueinbillionU.S.dollars050100150200250300350400UnitedHealthGroupInc.,U.S.CignaCorp.,U.S.335.94180.02ElevanceHealth,U.S.160.67146.25CenteneCorpHumanaInc.,U.S.95.64HCAHealthcareInc.,U.S.FreseniusSE&Co.KGaA,GermanyThermoFischerScientificInc.,U.S.AbbottLaboratories,U.S.MolinaHealthcareInc,U.S.60.884543.8141.5132.356Description:Thisstatisticshowsthe2023rankingoftheglobaltop10healthcareequipmentandservicescompaniesbasedonrevenue.ThevaluesweretakenfromtheFinancialTimesequityscreenerdatabase.U.S.healthcareproviderUnitedHealthGroupwasrankedfirst,withatotalrevenueofalmost336billionU.S.dollars.ReadmoreNote(s):Worldwide;asofMay2023Source(s):FinancialTimes;ThomsonReuters;Varioussources(companydata)Distributionoftheglobalrevenueofmedicaltechnologyindustryin2021,byregionDistributionofglobalrevenueofMedTechindustry2021,byregionAfrica3%SouthAmerica6.6%Asia-Pacific25.0%NorthAmerica36%Europe28.9%7Description:In2021,themedicaltechnologyindustrygeneratedrevenueofapproximately536billioneuros.ThisstatisticshowshowtheglobalMedTechrevenuewasdistributedacrossregions.Accordingtothedata,36percentoftheglobalrevenuewasgeneratedinNorthAmerica,whilethemarketinAsia-Pacificaccountedforapproximatelyonequarterofthetotalrevenueofthemedicaltechnologiesindustry.ReadmoreNote(s):WorldwideSource(s):Mediobanca;WorldBankCHAPTER

02APACmarketMedicaltechnologyrevenueintheAsia-Pacificregionfrom2019to2023,withforecaststo2028,bysegment(inbillionU.S.dollars)MedTechrevenueAPAC2019-2028,bysegmentMedicalDevicesInVitroDiagnostics1801601401201008029.0427.7426.6825.7325.0826.2425.0326.6216.6782.07201920.3277.372020137.332028*127.752027*60119.6111.482025*103.232024*95.51202296.38202387.022021402002026*9Description:In2023,themedicaltechnologyindustryintheAsia-Pacificregiongeneratedaround121billionU.S.dollarsinrevenue.Thatyear,themedicaldevicessegmentgeneratedrevenuesofover96billiondollars.

ReadmoreNote(s):2019to2028;*Forecast

DataprovidedbyMarketInsightsareestimates.

Definition:TheMedicalTechnologymarketcoversdevicesandproductsusedforprevention,diagnosis,andtreatmentofdiseases.Nextto[...]

ReadmoreSource(s):MedicaltechnologyrevenueintheAsia-Pacificregionfrom2019to2023,withforecaststo2028,bysubregion(inbillionU.S.dollars)MedTechrevenueAPAC2019-2028,bysubregionEastAsiaSoutheastAsiaSouthAsiaOceania1801601401201008011.9214.2111.2413.1610.6212.2410.0211.3718.21122.042028*9.4316.96114.132027*9.169.4312.029.169.8112.6415.8410.578.3314.748.3913.667.136.9311.427.37.3510.4210.1660107.59101.092025*94.6591.1589.885.54073.973.25202020020192021202220232024*2026*10Description:In2023,themedicaltechnologyindustryintheAsia-Pacificregiongeneratedaround121billionU.S.dollarsinrevenue.EastAsiageneratedcloseto90billiondollarsinmedicaltechnologyrevenuethatyear.ReadmoreNote(s):2019to2028;*Forecast

DataprovidedbyMarketInsightsareestimates.

Definition:TheMedicalTechnologymarketcoversdevicesandproductsusedforprevention,diagnosis,andtreatmentofdiseases.Nextto[...]

ReadmoreSource(s):MedicaltechnologyrevenueintheAsia-Pacificregionin2024,bycountry(inbillionU.S.dollars)MedTechrevenueAPAC2024,bycountryRevenueinbillionU.S.dollars20

250510153035404550ChinaJapan45.6934.66SouthKoreaIndia11.348.93AustraliaMalaysiaThailand7.963.662.772.711.9IndonesiaVietnamNewZealandSingaporePhilippines1.371.15111Description:In2024,themedicaltechnologyindustryinChinageneratedaround45.7billionU.S.dollarsinrevenue,thehighestacrosstheAsia-Pacificregion.Japanfollowedwithabout34.7billiondollarsinrevenue.ReadmoreNote(s):2024Source(s):MedicaldevicesrevenueintheAsia-Pacificregionfrom2019to2023,withforecaststo2028,bysegment(inbillionU.S.dollars)MedicaldevicesrevenueAPAC2019-2028,bysegmentCardiologyDevicesOphthalmicDevicesEndoscopicDevicesDiagnosticImagingDevicesGeneral&PlasticSurgeryDevicesDiabetesCareDevicesOrthopedicDevicesOtherMedicalDevicesDentalDevices160140120100806040200201920202021202220232024*2025*2026*2027*2028*12Description:In2023,themedicaldevicesindustryintheAsia-Pacificregiongeneratedaround96.4billionU.S.dollarsinrevenue.Cardiologydevicesaccountedforthebiggestsegmentatover13.5billiondollars.

ReadmoreNote(s):2016to2028;*Forecast

DataprovidedbyMarketInsightsareestimates.

Definition:TheMedicalDevicesmarketincludesinstrumentsandmachineshelpingfortheprevention,diagnosis,andtreatmentofdiseases.Thismarketis[...]

ReadmoreSource(s):MedicalserviceroboticsrevenueintheAsia-Pacificregionfromto2019to2023,withforecaststo2028,bysubregion(inbillionU.S.dollars)MedicalserviceroboticsrevenueAPAC2019-2024,bysubregionEasternAsiaSoutheastAsiaAustralia&OceaniaSouthernAsia4,0003,5003,0002,5002,0001,5001,0005000201920202021202220232024*2025*2026*2027*2028*13Description:In2023,themedicalserviceroboticsindustryinEastAsiageneratedaround1.75billionU.S.dollarsinrevenue,thehighestacrosstheAsia-Pacificregion.SoutheastAsiafollowedwithabout230milliondollarsinrevenue.

ReadmoreNote(s):2019to2023;*Forecast

DataprovidedbyMarketInsightsareestimates.

Definition:

TheCommercialServiceRoboticsmarketpresentsthemarketsizeofserviceroboticsincommercialusecases,e.g.,medicalrobots,logistic[...]

ReadmoreSource(s):MedicalserviceroboticsrevenueintheAsia-Pacificregionin2024,bycountry(inbillionU.S.dollars)MedicalserviceroboticsrevenueAPAC2024,bycountryRevenueinmillionU.S.dollars400

5000100200300600700800900ChinaJapan784.57517.03SouthKoreaAustralia262.94214.34SingaporeVietnam152.5245.1744.64MalaysiaThailand13.3810.729.56PhilippinesNewZealandIndonesia6.914Description:In2024,themedicalserviceroboticsindustryinChinageneratedaround784.6millionU.S.dollarsinrevenue,thehighestacrosstheAsia-Pacificregion.Japanfollowedwithabout517milliondollarsinrevenue.

ReadmoreNote(s):2024Source(s):CHAPTER

03TradeImportvalueofmedicalorsurgicalinstrumentsintheAsia-Pacificregionin2022,bycountryorterritory(inmillionU.S.dollars)Medicalorsurgicalinstruments'importvalueAPAC2022,bycountryImportvalueinmillionU.S.dollarsChina12,079.52JapanAustraliaSouthKoreaIndia6,940.662,614.332,498.62,315.452,067.211,922.131,309.551,000.72749.34719.79476.4467.06SingaporeHongKongTaiwanMalaysiaThailandIndonesiaNewZealandVietnam16Description:In2022,Chinaimportedmedicalandsurgicalinstrumentsequivalenttoapproximately12.08billionU.S.dollars,recordingthehighestfigureintheAsia-Pacificregion.Incontrast,theimportvalueofequipmentinthesameproductgroupinNorthKoreawasaround3.8milliondollarsthatyear.ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeExportvalueofmedicalorsurgicalinstrumentsintheAsia-Pacificregionin2022,bycountryorterritory(inthousandU.S.dollars)Medicalorsurgicalinstruments'exportvalueAPAC2022,bycountryExportvalueinthousandU.S.dollarsChina10,471,820JapanSingaporeSouthKoreaMalaysiaHongKongIndia5,736,7993,084,9022,504,3332,350,7061,485,1811,232,070985,614802,767651,002491,126447,039236,318VietnamThailandTaiwanAustraliaPakistanPhilippines17Description:In2022,ChinawasbyfarthelargestexporterofmedicalandsurgicalinstrumentsintheAsia-Pacificregion,withanexportvalueofabout10.5billionU.S.dollars.Incontrast,theexportvalueforthesameproducttypesfromTimor-Lestewasaround13thousanddollarsthatyear.ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeTradebalanceofmedicalorsurgicalinstrumentsintheAsia-Pacificregionin2022,bycountryorterritory(inthousandU.S.dollars)Medicalorsurgicalinstruments'tradebalanceAPAC2022,bycountryTradebalanceinthousandU.S.dollarsMalaysia1,349,986SingaporeVietnam1,017,692518,558Pakistan142,670Thailand53,4235,734SouthKoreaNorthKoreaTimor-LesteBhutan-3,214-3,921-5,607Laos-7,916PapuaNewGuineaBrunei-12,412-18,878-19,211Maldives18Description:In2022,Malaysiahadamedicalandsurgicalinstrumentstradesurplusofapproximately1.35billionU.S.dollars.Incontrast,thetradebalanceofAustraliaforthesameproducttypeswasaroundnegative2.12billionU.S.dollarsthatyear.

ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeImportvalueoforthopedicdevicesintheAsia-Pacificregionin2022,bycountryorterritory(inthousandU.S.dollars)Orthopedicdevices'importvalueAPAC2022,bycountryImportvalueinthousandU.S.dollarsChinaJapan3,926,7152,960,318AustraliaSingaporeSouthKoreaIndia1,521,3111,157,6651,023,878752,635Taiwan451,740371,363363,977304,389VietnamHongKongNewZealandMalaysia272,671233,265ThailandPhilippines212,11219Description:In2022,China'simportvalueoforthopedicdeviceswasapproximately3.93billionU.S.dollars,recordingthehighestfigureintheAsia-Pacificregion.Incontrast,theimportvalueofitemsinthesameproductgroupinTimor-Lestewasaround48thousanddollarsthatyear.ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeExportvalueoforthopedicdevicesintheAsia-Pacificregionin2022,bycountryorterritory(inthousandU.S.dollars)Orthopedicdevices'exportvalueAPAC2022,bycountryExportvalueinthousandU.S.dollarsSingaporeChina2,781,6622,383,900MalaysiaSouthKoreaHongKongAustraliaVietnam1,309,407922,317593,501316,745272,443259,525174,396IndiaTaiwanPhilippinesJapan153,351133,761122,185ThailandBangladesh13,74920Description:In2022,SingaporewasthelargestexporteroforthopedicdevicesandappliancesintheAsia-Pacificregion,withanexportvalueofabout2.8billionU.S.dollars.Incontrast,theexportvaluesforthesameproducttypesfromTimor-LesteandMyanmarweretwothousandandonethousanddollars,respectively.ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeTradebalanceoforthopedicdevicesintheAsia-Pacificregionin2022,bycountryorterritory(inthousandU.S.dollars)Orthopedicdevices'tradebalanceAPAC2022,bycountryTradebalanceinthousandU.S.dollarsSingaporeMalaysia1,623,9971,036,736HongKongNorthKoreaTimor-LesteAfghanistanPapuaNewGuineaBhutan229,524719-46-223-235-466Laos-841CambodiaMyanmar-870-1,239-2,281-2,284BruneiMaldives21Description:In2022,Singapore'stradesurplusinorthopedicdevicesamountedtoapproximately1.62billionU.S.dollars.Incontrast,thetradebalanceofJapanforthesameproducttypeswasaroundnegative2.83billiondollarsthatyear.

ReadmoreNote(s):Asia,APAC;2022Source(s):InternationalTradeCentre;TradeMap;UNComtradeCHAPTER

04CompaniesLeadinghealthcaretechnologyunicornsinAsiaasofFebruary2023,byvaluationLeadingHealthTechunicornsAsia2023,byvaluationValuationinbillionU.S.dollars012345678WeDoctor(GuaHao)(China)HuishengBioPhar(China)Medlinker(China)753.9AbogenBio(China)3.7YikonGenomics(China)Austrianova(Singapore)YITU(China)32.42.1MolbioDiagnostics(India)Shukun(China)MediTrustHealth(China)ValgenMedtech(China)PristynCare(India)1.61.51.51.41.41.3RonovoSurgical(China)23Description:AsofFebruary2023,ChinesetelehealthproviderWeDoctor(GuaHao)wasthehighestvaluedhealthcaretechnologyunicorninAsia,withavaluationofsevenbillionU.S.dollars.Singapore'sprecisionmedicinecompanyAustrianovawasvaluedat2.4billiondollarsthatmonth,makingitthehighestrankingHealthTechunicorninAsiaoutsideofChina.ReadmoreNote(s):Asia,APAC;asofFebruary1,2023;privatecompanieswithvaluationsoveronebillionU.S.dollarsSource(s):HolonIQNumberofhealthcaretechnologyunicornsinAsiaasofFebruary2023,bysegmentNumberofHealthTechunicornsAsia2023,bysegmentNumberofunicorncompanies0.00.51.01.52.02.53.03.54.04.5HealthdiscoveryPrecisionmedicineTelehealth43222222DiagnosistechnologyPracticemanagementHealthroboticsHealthinsuranceHealthrecordsChroniccare11111SpecialistcareWearablesDevicesClinicaltrials24Description:AsofFebruary2023,fouroutofthe31HealthTechunicornsinAsiaoperatedinthehealthdiscoverysegment.ꢀThatmonth,ChinesetelehealthproviderWeDoctor(GuaHao)wasthehighestvaluedhealthcaretechnologyunicorninAsia,withavaluationofsevenbillionU.S.dollars.ReadmoreNote(s):Asia,APAC;asofFebruary1,2023;privatecompanieswithvaluationsoveronebillionU.S.dollarsSource(s):HolonIQDistributionoftop50HealthTechcompaniesinSoutheastAsiafrom2021to2023,bycountryDistributionoftop50HealthTechcompaniesSEA2021-2023,bycountryPhilippinesThailandMalaysiaVietnamIndonesiaSingapore120%100%80%60%40%20%0%66%16%68%72%11%18%6%6%6%11%2%4%4%2%4%2%2%0%20212022202326Description:In2023,66percentoftheleading50SoutheastAsianHealthTechcompanieswerefromSingapore.TheshareofcompaniesfromMalaysiaincreasedfromtwopercentin2021tosixpercentin2023.

ReadmoreNote(s):Asia;2021to2023Source(s):HolonIQCHAPTER

05GlobaloutlookShareofcliniciansworldwidewhohadpatientswhichusedhealthmonitoringtools(suchaswearables)andtheirforecastprevalenceinfiveyears'timeasof2023,byregion/countryClinicians'currentexperiencewithwearablesandforecastfutureuseworldwide2023ShareofclinicaldecisionsExpectedin5years20%Currentexperience30%0%10%40%50%60%45%TotalAsiaPacific27%50%33%42%42%Europe21%24%21%NorthAmericaSouthAmericaChina37%52%36%43%42%UnitedKingdomUnitedStates22%24%28Description:Accordingtoasurveycarriedoutin2023,cliniciansinChinareported36percentofpatientsusedmonitoringtoolssuchaswearablestoassesstheirhealthandwell-being,withtheprevalenceat33percentinthewiderAsiaPacificregion.Infiveyears'time,cliniciansinChinaexpected52percentoftheirpatientswillbeusingwearables.ReadmoreNote(s):Worldwide;AprilandMay,2023;2,607respondents;CliniciansSource(s):ElsevierShareofclinician'sdecisionsbasedonAItoolssuchasChatGPT/Bardworldwideasof2023,byregion/countryShareofclinicaldecisionsbasedonAItoolssuchasChatGPT/Bardworldwide2023Shareofclinicaldecisions0%2%4%6%8%10%12%14%16%18%20%TotalAsiaPacific11%19%19%Europe6%NorthAmericaSouthAmericaChina7%9%UnitedKingdomUnitedStates8%8%29Description:Accordingtoasurveycarriedoutin2023,justunderafifthofclinicaldecisionsinAsiaPacificwerebasedonAItoolssuchasChatGPT/Bard.InNorthAmerica,sevenpercentofclinicaldecisionswerereportedtobebasedonAItools.

ReadmoreNote(s):Worldwide;AprilandMay,2023;2,607respondents;CliniciansSource(s):ElsevierShareofclinicianswhobelievedthefutureuseofAItoolssuchasChatGPT/Bardtomakeclinicaldecisionswouldbedesirableasof2023,byregion/countryClinicians'opinionsonthedesirabilityofChatGPT/Barduseinfuture2023Shareofclinicaldecisions0%10%20%30%40%39%50%48%60%TotalAsiaPacific55%55%EuropeNorthAmericaSouthAmericaChina42%42%5